Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis
Status:
Unknown status
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
Fatigue is a common symptom in multiple sclerosis (MS) that is characterized by physical
and/or mental exhaustion. Fatigue is difficult to treat and treatment efficacy of available
therapy is limited. The goal of this study is to determine whether MS-associated fatigue
improves after 6 weeks of methylphenidate therapy. Treatment efficacy will be measured by a
questionnaire called "Fatigue Severity Scale" (FSS).